Halozyme Therapeutics, Inc. (HALO) Social Stream



Halozyme Therapeutics, Inc. (HALO): $49.00

3.30 (+7.22%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add HALO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#25 of 333

in industry

Featured Post From StockTwits About HALO

After recent Biotech clean up here is where my conviction / positions stand
- $HZNP / $HALO ( commercial , cash flow positive, sleeping pretty well with these)
- ARWR / DRNA ( dev stage RNAi plays, cash burn is offset by partnerships, kinda sleep well 😬)
- $MYOV $GBT initiated recently at current lelevs. *Regulatory* derisked small caps with decent ongoing launch. Plenty of upside if management does not fck up things
- $ZGNX - tiny position, may sell if it bounces, but Fintepla is doing great for now. There is ongoing ANDA litigation, so that's the main risk. Everyone remembers AMRN, right?

Be ruthless in bios. Thesis changes, management does not deliver, poor financial decisions, etc - sell. Waiting and hoping to break even in this field is direct way to hell
humour, published August 12, 2021

What Else are HALO Traders Talking About?


Other tickers frequently mentioned alongside HALO are HZNP, MYOV, GBT and ZGNX.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!